Quality Assurance and Regulatory Affairs
Regulatory Strategy & Device Classification
Building a Regulatory Roadmap for Market Success
In today’s dynamic and tightly regulated medical device industry, establishing a clear and effective regulatory strategy is essential. Rather than being limited to documentation and approvals, a regulatory strategy acts as a strategic framework that guides manufacturers through the complexities of global compliance. It ensures that product development remains aligned with regulatory expectations, enabling timely market entry and long-term success.
Unlike a basic regulatory plan that may simply outline tasks and deadlines, a true strategy encompasses the full product lifecycle. This includes initial classification, necessary testing and clinical evaluations, identification of target markets, regulatory submissions, and ongoing post-market obligations. Regardless of the device’s risk level, a comprehensive strategy can significantly mitigate regulatory risks and improve global positioning.
Our Regulatory Support Services
Device risk classification assessment
Identification of the target markets and regulatory pathways
Regulatory gap analysis
- Technical documentation review and remediation
- Labeling, packaging, and Instructions for Use (IFU)
- Quality Management Systems (QMS)
Regulatory submission planning
- Submission types
- Timelines and key milestones
- Role assignments
Predictive regulatory analysis to identify upcoming standards, regulatory changes, and regional shifts impacting approvals
Regulatory authority liaising and post-submission support
Notified body (NB) deficiency response handling and query drafting/coordination
Integration of the Global Harmonization Initiative (GHI) to streamline multi-region compliance
Alignment of regulatory strategy with product development
- Design inputs
- Risk management
- Testing protocols
- Clinical trial planning
Proactive Compliance & Regulatory Intelligence for Global Market Access
The inclusion of predictive regulatory analysis, leveraging data trends and AI-driven insights, helps anticipate upcoming changes in global regulatory frameworks. This forward-thinking approach, combined with active participation in Global Harmonization Initiatives (GHIs) driven by the IMDRF and WHO, ensures our clients remain prepared and compliant across major markets.